Vol. 276, Issue 6, R1647-R1652, June 1999
Ontogeny of estrogen sulfatase activity in ovine fetal
hypothalamus, hippocampus, and brain stem
Scott C.
Purinton1,
Howard
Newman1,
Maria I.
Castro2, and
Charles E.
Wood1
1 Department of Physiology,
College of Medicine; and
2 Department of
Pharmacodynamics, College of Pharmacy, University of Florida,
Gainesville, Florida 32610
 |
ABSTRACT |
Ovine parturition is initiated by
increases in fetal hypothalamus-pituitary-adrenal (HPA) axis activity,
which in turn increase placental estrogen biosynthesis and ultimately
increase uterine contractility. In addition to the action in the
uterus, estrogens augment fetal ACTH secretion. In late
gestation, estrone sulfate is more abundant in fetal plasma than is
unconjugated estrone. We studied hypothalamus, hippocampus, and brain
stem tissue from fetal, neonatal, and adult sheep to test the
hypothesis that the ovine brain contains estrogen sulfatase activity.
We found that the activity in the hippocampus was significantly
increased in late-gestation fetuses compared with both younger and
older animals. No significant change in either hypothalamus or brain
stem was revealed; however, the activity in all brain areas was high.
Immunohistochemistry revealed the presence of estrogen sulfatase in the
paraventricular nucleus of the hypothalamus, the nucleus of the
solitary tract, and the rostral ventrolateral medulla. We conclude that
ovine fetal hypothalamus, hippocampus, and brain stem contain estrogen sulfatase activity and that the activity in the hippocampus is developmentally regulated.
steroid; estrone; development; sheep; labor; parturition; central
nervous system
 |
INTRODUCTION |
IN OVINE PREGNANCY, developmental changes in the
synthesis of estrogens and progesterone are important for the
initiation, maintenance, and spontaneous termination of the pregnancy.
Our interests have focused on the mechanisms controlling spontaneous parturition. In the ovine fetus, parturition is initiated by an increase in the activity of the fetal hypothalamus-pituitary-adrenal (HPA) axis (12). The resultant increase in fetal plasma cortisol induces the activity of cytochrome
P-450C-17 in the placenta
(14). This enzyme has both 17
-hydroxylase and
17,20-lyase activities; induction of this enzyme allows
proportionately more estrogen and proportionately less progesterone
biosynthesis. The increase in the so-called
"estrogen-to-progesterone" ratio, in plasma and locally (within
the uterine tissues), allows increased uterine contractility (12). It
is the increased uterine tone that initiates labor and delivery of the fetus.
We have recently demonstrated that physiological increases in fetal
plasma estrogen concentrations greatly augment fetal ACTH secretion
(20). This effect of estrogen can be demonstrated on both basal and
hypotension-stimulated fetal ACTH secretion. Although estrogen has a
potentially important effect on fetal ACTH secretion, it is well known
that fetal plasma concentrations of unconjugated estrogens increase
only after the beginning of the increase in fetal plasma ACTH and
cortisol (16, 23). Conjugated estrogens, mostly estrone sulfate,
circulate in high concentrations compared with unconjugated estrogens
(2, 24). The concentration of estrone sulfate increases before the
increase in fetal HPA axis activity (16). However, conjugated steroids
cannot bind to nuclear receptors unless deconjugated (5). It is
possible that estrone sulfate is converted to estrone locally within
the fetal brain and that the circulating estrone sulfate acts as a reservoir for estrone acting within the fetal brain.
Estrogen sulfatase activity has been reported in brain tissue from
adult sheep (9, 15), rats (3, 7), primates (10), and humans (17).
Activity of this enzyme has not been investigated in fetal sheep. We
hypothesized that estrogen sulfatase activity could be demonstrated in
hypothalamus, hippocampus, and brain stem of fetal sheep and that the
activity changes as a function of fetal gestational age. We further
hypothesized that estrogen sulfatase would be present throughout the
final trimester of fetal development, as well as in the postnatal
animal, in brain regions relevant for HPA axis control. The experiments
reported in this paper were designed to test these hypotheses.
 |
MATERIALS AND METHODS |
Enzyme activity. We studied fetuses
(86-147 days gestation, term = 147 days), four lambs (3-4 wk
old), and four adult nonpregnant ewes to determine estrone sulfatase
activity. The sheep were killed with an intravenous overdose of
pentobarbital sodium. Gestational ages of the fetal sheep were
calculated from known breeding dates. Whole brains were rapidly
removed, dissected into discrete regions, and quickly frozen on dry ice
or in a slurry of dry ice and acetone. All tissues were stored at
20 or
40°C until studied.
Hypothalami, brain stems, and hippocampi were then processed to
determine estrone sulfatase activity. Each tissue sample was homogenized in medium 199 (Sigma, St. Louis, MO) containing 25 mM
HEPES. Homogenization was performed using a Polytron homogenizer (Tekmar, Cincinnati, OH). The concentration of each tissue in the
homogenate was 0.5 g tissue in 5 ml medium.
Tissues were centrifuged at 1,200 rpm for 5 min; supernatant was then
collected and assayed immediately. A sample of each homogenate was
assayed for protein concentration according to the method of Bradford
(1) with a commercially available assay kit (Bio-Rad Laboratories,
Hercules, CA). Homogenate (0.1 ml) was aliquoted in duplicate into
borosilicate tubes (16 × 150 mm) containing 0.8 ml of a mixture
of [6,7-3H]estrone
sulfate (DuPont-NEN, Wilmington, DE) and unlabeled estrone sulfate
(E1SO4;
Sigma). All reactions were run at 37°C. Reactions were terminated
by immediate cooling on ice, addition of 5 volumes of ethyl
acetate:hexane (3:2), and vigorous mixing for 30 s. The aqueous phase
was frozen by submersion of the reaction tube into a dry ice and
acetone slurry. Subsequently, the organic phase containing the
[3H]estrone
was decanted into 13 × 75-mm borosilicate glass tubes and dried
under a gentle stream of room air. Dried extracts were reconstituted in
scintillant (Cytoscint; ICN, Costa Mesa, CA) and counted in a
scintillation counter (LKB, Gaithersburg, MD).
Enzyme activities at different developmental ages and in different
tissues were measured using a substrate concentration of 3 µM and
[3H]estrone sulfate
specific activity of ~0.67 µCi/nmol. For this experiment, reactions
were allowed to run for 5 min. Under these conditions, <20% of the
substrate was converted to
[3H]estrone.
Comparison of relative activities at different developmental ages was
achieved with one-way ANOVA. A posteriori comparison of individual mean
values was performed with Newman-Keuls multiple range test (26).
Comparison of two means was performed with Student's
t-test (27). All statistical
computations were performed with SigmaStat (Jandel Scientific, San
Rafael, CA).
Western blotting. Hypothalami and
brain stems were harvested from fetuses, lambs, and adults of known
gestational and postnatal ages. The number and ages of animals varied
slightly between hypothalami and brain stem, but 11-12 fetuses,
3-4 lambs, and 2 adults were used per tissue type. These tissues
were originally obtained and homogenized for other studies (19).
Unfortunately, hippocampi from these animals were not available. All
tissue was homogenized in reducing buffer and boiled for 5 min. The
samples were centrifuged to remove particulate matter, and supernatant
was recovered. Protein concentrations were obtained with the use of the
Bradford technique (1). Western blots were performed with a
mini-Protean electrophoresis system (Bio-Rad) on 10% precast
polyacrylamide gels purchased from Bio-Rad Laboratories. Samples were
diluted so that an equal amount of protein was loaded per lane (20 µg
for brain stem and 40 µg for hypothalami). The protein was then
transferred to a nitrocellulose membrane and probed for estrogen
sulfatase with a custom-made rabbit polyclonal antibody (Alpha
Diagnostic, San Antonio, TX). The peptide sequence used from the human
sulfatase gene, amino acids 294-309, was
NH2-FSSKDFAGKSQHGVYGC-COOH (21). Primary antibody was diluted to a concentration of 1:1,000 in antibody
diluent (1% BSA in PBS with 0.05% Tween 20). Visualization of the
protein-antibody complex was accomplished with a chemiluminescence detection system (Renaissance; DuPont-NEN, Boston, MA) and analyzed by
densitometry (Bio-Rad). Antibody specificity was confirmed by
preabsorption of the primary antibody with a peptide (1 µg/ml), also
supplied by Alpha Diagnostic. Developmental changes were calculated
with multiple linear regression to control for differences between gel
running conditions (SigmaStat).
Immunohistochemistry. Fetal brains
were perfusion-fixed with 4% paraformaldehyde, dissected, and cut into
gross tissue regions (hypothalamus, midbrain, pons, medulla, spinal
cord, etc.). Tissue was processed for embedding by dehydration with
progressively increasing concentrations of ethanol followed by xylene.
All tissue was embedded in paraffin and cut into 10-µm sections with
a Zeiss microtome. Sections were mounted on
poly-L-lysine slides,
deparaffinized with xylene, and rehydrated in decreasing concentrations
of ethanol. Immunohistochemistry and visualization were made possible
with a Histostain-SP kit from Zymed and a metal-enhanced
diaminobenzidine (Pierce, Rockford, IL). Sections were
stained for estrogen sulfatase with the same custom-made antibody used
for Western blotting. Primary antibody was diluted to a concentration
of 1:500 in antibody diluent (1% BSA in PFS 0.01% with Triton X-100).
Specific staining was confirmed by dilution tests; staining decreased
as primary antibody was further diluted. Specific staining
was absent after primary antibody was replaced with 10% normal
goat serum. All slides were dehydrated before being
mounted on coverslips with Permount (Fisher Scientific,
Pittsburgh, PA).
 |
RESULTS |
Enzyme activity. Estrogen sulfatase
activity was measurable in ovine fetal, neonatal, and adult
hypothalamus, hippocampus, and brain stem (Fig.
1). The activity in the hippocampus was
significantly increased in late-gestation fetuses compared with younger
fetuses, lambs, and adult ewes as tested by ANOVA and Newman-Keuls
multiple range test (n = 3 or 4/group;
P < 0.01). The activity in
hypothalamus appeared to decrease in more mature animals, but this was
not statistically significant, possibly caused in part by insufficient numbers in each group. The activity in brain stem was highly variable and overall did not change as a function of age.

View larger version (20K):
[in this window]
[in a new window]
|
Fig. 1.
Estrone sulfatase activity in ovine hippocampus
(A), hypothalamus
(B), and brain stem
(C) for fetuses 119-129,
134-138, and 140-147 days old, lambs, and adult ewes. For all
reactions, velocity is expressed as picomoles estrone formed per minute
per milligram protein. Substrate concentration in all reactions was 3 µM. Data are means ± SE (n = 3 or 4 sheep/group). Activity in hippocampus was significantly increased
in late-gestational fetuses compared with younger fetuses, lambs, and
adult ewes (n = 3 or 4/group,
P < 0.01).
|
|
As shown in Fig. 2, the activity of the
estrogen sulfatase within these brain regions is very high, even
compared with ovine myometrium. When compared by Student's
t-test, the activity in ovine adult
hypothalamus was significantly different from the activity in ovine
myometrium (n = 3/group;
P < 0.001).

View larger version (13K):
[in this window]
[in a new window]
|
Fig. 2.
Estrone sulfatase activity in ovine myometrium
(n = 3 samples) and hypothalamus
(n = 3 samples). Activity is expressed
as picomoles estrone formed per minute per 10 mg tissue wet weight.
Substrate concentration in all reactions was 3 µM.
|
|
Western blotting. For Western
blotting, tissues were distributed among gels so that each gel
contained a subset of the developmental ages studied. For brain stem,
12 fetuses, 3 lambs, and 2 adults were used. The developmental ages
were as follows: fetuses 90-110 days
(n = 3), 119-129 days
(n = 4), 134-138 days
(n = 3), and 140-147 days old
(n = 2); lambs 1-21 days old
(n = 3); and adult ewes
(n = 2). Western blots
revealed three distinct bands at 66, 45, and 30 kDa. The 66-kDa band is
shown in Fig. 3 and corresponds to the
correct molecular mass of 65,492 Da for estrogen sulfatase (22). As shown by Fig. 3, there are slight molecular mass variations of
the 66-kDa band for ovine brain stem. Preabsorption of the enzyme
revealed the 66-kDa band to be specific, whereas the lower molecular
mass bands were shown to be nonspecific. Multiple linear regression did
not reveal the 66-kDa band to vary between groups. Figure
4A shows
group means ± SE measured in relative optical density across
developmental age for the 66-kDa band present in brain stem.

View larger version (45K):
[in this window]
[in a new window]
|
Fig. 3.
Western blots showing 66-kDa band of estrogen sulfatase for ovine
hypothalami and brain stems. Number below each band designates
developmental age in days. L, lamb; A, adult ewe.
|
|

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 4.
Estrogen sulfatase (66-kDa band) in ovine brain stem
(A) and hypothalamus
(B). Bars represent means ± SE
of designated age groups from Western blot analyses plotted as relative
optical density units (n = 2-4
samples/group).
|
|
For hypothalamic tissue, 12 fetuses, 4 lambs, and 2 adults were used.
The developmental ages were as follows: fetuses 86-110 days
(n = 2), 119-129 days
(n = 4), 134-138 days
(n = 3), and 140-147 days old
(n = 3); lambs 1-21 days old
(n = 4); and adults (n = 2). Western blots again revealed
three distinct bands at 66, 45, and 30 kDa. Again, preabsorption of the
enzyme revealed only the 66-kDa band to be specific. Western blots
showing the 66-kDa band for ovine hypothalamus as well as brain stem
are shown in Fig. 3. The 66-kDa band was not statistically different
between groups by multiple linear regression. Figure
4B shows group means ± SE measured
in relative optical density across developmental age for the 66-kDa
band present in hypothalami.
Immunohistochemistry. Specific
staining for estrogen sulfatase was widespread throughout the
hypothalamus and brain stem of all developmental and postdevelopmental
groups. Immunohistochemical results from regions important for HPA axis
control are shown in Fig. 5. Specific
neuronal staining was seen in the paraventricular nucleus (PVN) of the
hypothalamus (Fig. 5, A and
B), the nucleus of the solitary
tract (NTS) of the medulla (Fig. 5, C
and D), the rostral ventrolateral
medulla (RVLM) (Fig. 5E), and the
raphe nucleus (Fig. 5F).

View larger version (167K):
[in this window]
[in a new window]
|
Fig. 5.
A and
B: photomicrographs of neuronal
estrogen sulfatase staining in fetal ovine paraventricular nucleus
(A: ×40;
B: ×200).
C and
D: photomicrographs of neuronal
estrogen sulfatase staining in fetal ovine nucleus of the solitary
tract (C: ×100;
D: ×200).
E: photomicrograph of neuronal
estrogen sulfatase staining in fetal ovine rostral ventrolateral
medulla (×200). F:
photomicrograph of estrogen sulfatase staining in fetal ovine raphe
nucleus (×40).
|
|
 |
DISCUSSION |
The results of this study demonstrate that there is significant
estrogen sulfatase activity in ovine fetal hypothalamus, hippocampus, and brain stem and that there are statistically significant ontogenetic changes in activity of this enzyme in the hippocampus. We have previously demonstrated that estrogens in fetal plasma increase both
basal and stimulated fetal plasma ACTH secretion. The present results
suggest a mechanism by which the most abundant form of estrogen in
ovine fetal plasma, estrone sulfate, might be made available to areas
within the fetal brain known to be involved in the control of the fetal
HPA axis.
Mathew and Balasubramanian (15) and Lakshmi and Balasubramanian (9)
have previously demonstrated estrogen sulfatase activity in adult sheep
brain tissue. Other investigators have demonstrated this enzymatic
activity in adult brain tissue from rats (3, 7), mice (6), nonhuman
primates (10), and humans (17). Hobkirk et al. (6) demonstrated that
the enzyme activity is transiently increased postnatally in the brain
of the mouse. Although the development of brain estrogen sulfatase
activity has not been studied in sheep, the development of activity in
mice suggests the possibility that this might be an important
developmental process in the perinatal period.
In the present study, we found an unequal distribution of estrogen
sulfatase activity in the brain regions studied, and we found that the
developmental changes in activity were not identical among the regions.
Among the areas that we studied, we found highest activity in the
hippocampus and lower but still substantial activity in the
hypothalamus and brain stem. Western blotting in the hypothalamus and
brain stem confirmed the enzyme activity results. Thus estrogen sulfatase was present throughout development in both hypothalami and
brain stem, but it did not change significantly between groups. The
presence of multiple bands (66, 45, and 30 kDa) is not surprising because the primary antibody used was polyclonal. The 66-kDa band best
represents the enzyme that has a molecular mass of 65,492 Da (22) and
was the only band that was specific as tested by preabsorption. This
band was shown to be nonsignificant across developmental age (Fig. 4),
which agrees with the results of the enzyme kinetics. The 66-kDa band
for brain stem exhibited slight variations in molecular mass as shown
by Fig. 3. Although no previous evidence exists in the literature for
such an observation, a probable explanation may exist through
posttranslational modification. That is, events such as phosphorylation
or glycosylation could be responsible for slight variations in
molecular mass.
Using a histochemical technique, Kawano and Aikawa (7) found
that sulfatase activity is highest in pineal gland, choroid plexus, and
pars distalis of the pituitary in adult rats. We investigated the
activity in hypothalamus, brain stem, and hippocampus because these
areas are known to contain nuclei involved in integration, afferent
signal relay, or negative feedback inhibition within the HPA axis (4,
8, 13, 25). The presence of activity in any of these areas could be
important for the deconjugation of sulfated estrogens in the blood
perfusing the brain. Rosenfeld et al. (18) in 1980 reported that the
majority of estrogen produced by the ovine placenta is sulfoconjugated
and thus protected because sulfatase is not present. Our data suggest
otherwise inasmuch as sulfoconjugates in the fetal compartment may have
specific regional roles. The effect of estrogen on both basal and
hypotension-stimulated concentrations of ACTH could be the result of an
action of estrogen on the PVN in the hypothalamus, the hippocampus
(which mediates some of the negative feedback actions of
corticosteroids on ACTH secretion), the NTS (which relays neural
traffic from visceral afferents), or any part of the pathways leading
from the NTS to the PVN (e.g., the RVLM). Estrogen receptors have been
demonstrated in the NTS and hippocampus (11). Although estrogen
receptors within the hypothalamus are most concentrated in the arcuate
nucleus, estrogen receptors have been demonstrated in the PVN (11, 21). The results of the present experiments identify the cellular location of the sulfatase activity, which is consistent with these centers for
HPA axis control. We found widespread staining throughout nuclei and
fiber tracts of the hypothalamus and brain stem. Neuronal staining was
much more concentrated than fiber tract staining; however, both were
observable. Specifically, we found intense neuronal staining in the PVN
(Fig. 5, A and
B), the NTS (Fig. 5,
C and
D), the RVLM (Fig.
5E), and the dorsal raphe nucleus (Fig. 5F).
Perspectives
We propose that parturition in the sheep and possibly other species
involves an interaction among several variables whose net result is the
activation of the HPA axis. In sheep, increases in fetal plasma
cortisol concentration induce placental synthesis of estrogens. In
nonhuman primates and humans, increases in fetal plasma ACTH stimulate
fetal adrenal secretion of dehydroepiandrosterone, which is then
converted to estrogen by the placenta. We have recently reported that
physiological increases in fetal plasma estrogen concentrations
stimulate fetal ACTH secretion (19) and that physiological increases in
fetal plasma androgen concentrations decrease the sensitivity of the
fetal hypothalamopituitary unit to negative feedback inhibition by
cortisol (19). Therefore, the increases in fetal plasma estrogen and
androgen concentrations, themselves in part a function of fetal HPA
axis activity, further augment fetal ACTH secretion. We hypothesize
that parturition results from the onset of a hypothalamic drive to ACTH
secretion, with interaction between adrenal, placenta, and hypothalamus
producing a positive feedback cycle, which ultimately concludes with
the separation of placenta from the fetal HPA axis
(parturition). The present study suggests that the
influence of estrogens on HPA axis activity could be expressed earlier
than would be predicted on the basis of changes in plasma
concentrations of unconjugated forms.
 |
ACKNOWLEDGEMENTS |
We thank Dr. Maureen Keller-Wood and Dr. Bruce Stevens for
insightful comments and help along the way.
 |
FOOTNOTES |
This work was supported by Grant HD-24250 from the National Institute
of Child Health and Human Development and by a Grant-in-Aid from the
American Heart Association, Florida Affiliate.
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement"
in accordance with 18 U.S.C. §1734 solely to indicate this fact.
Address for reprint requests and other correspondence: C. E. Wood,
Dept. of Physiology, Box 100274, JHMHC, Univ. of Florida College of
Medicine, Gainesville, FL 32610-0274 (E-mail:
cwood{at}phys.med.ufl.edu).
Received 16 June 1998; accepted in final form 3 February 1999.
 |
REFERENCES |
1.
Bradford, M. M.
A refined and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.
Anal. Biochem.
72:
248-254,
1976[Medline].
2.
Carnegie, J. A.,
and
H. A. Robertson.
Conjugated and unconjugated estrogens in fetal and maternal fluids of the pregnant ewe: a possible role for estrone sulfate during early pregnancy.
Biol. Reprod.
19:
202-211,
1978[Abstract].
3.
Connolly, P. B.,
and
J. A. Resko.
Estrone sulfatase activity in rat brain and pituitary: effects of gonadectomy and the estrous cycle.
J. Steroid Biochem.
33:
1013-1018,
1989[Medline].
4.
Grizzle, W. E.,
M. F. Dallman,
L. P. Schramm,
and
D. S. Gann.
Inhibitory and facilitatory hypothalamic areas mediation ACTH release in the cat.
Endocrinology
95:
1450-1461,
1974[Medline].
5.
Hobkirk, R.
Steroid sulfotransferases and steroid sulfate sulfatases: characteristics and biological roles.
Can. J. Biochem. Cell Biol.
63:
1127-1144,
1985[Medline].
6.
Hobkirk, R.,
J. M. Fletcher,
and
H. Y. Choi.
Estrone sulfate sulfohydrolase in the developing brain and pituitary of rat, mouse and guinea pig.
J. Steroid Biochem.
26:
413-416,
1987[Medline].
7.
Kawano, J.,
and
E. Aikawa.
Regional distribution of arylsulphatase and estrone-sulfate sulfatase activities in rat brain and hypophysis.
Brain Res.
409:
391-394,
1987[Medline].
8.
Keller-Wood, M.,
and
M. F. Dallman.
Corticosteroid inhibition of ACTH secretion.
Endocr. Rev.
5:
1-22,
1984[Medline].
9.
Lakshmi, S.,
and
A. S. Balasubramanian.
Studies on the chaotropically solubilized arylsulfatase C and estrone sulfatase of sheep brain.
Biochim. Biophys. Acta
567:
184-195,
1979[Medline].
10.
Lakshmi, S.,
and
A. S. Balasubramanian.
The distribution of estrone sulphatase, dehydroepiandrosterone sulphatase, and arylsulphatase C in the primate (Macaca radiata) brain and pituitary.
J. Neurochem.
37:
358-362,
1981[Medline].
11.
Lehman, M. N.,
F. J. P. Ebling,
S. M. Moenter,
and
F. J. Karsch.
Distribution of estrogen receptor-immunoreactive cells in the sheep brain.
Endocrinology
133:
876-886,
1993[Abstract].
12.
Liggins, G. C.,
R. J. Fairclough,
S. A. Grieves,
J. Z. Kendall,
and
B. S. Knox.
The mechanism of initiation of parturition in the ewe.
Recent Prog. Horm. Res.
29:
111-159,
1973.
13.
Maran, J. W.,
D. E. Carlson,
W. E. Grizzle,
D. G. Ward,
and
D. S. Gann.
Organization of the medial hypothalamus for control of adrenocorticotropin in the cat.
Endocrinology
103:
957-970,
1978[Abstract].
14.
Mason, J. I.,
J. T. France,
R. R. Magness,
B. A. Murry,
and
C. R. Rosenfeld.
Ovine placental steroid 17
-hydroxylase/C-17,20 lyase, aromatase, and sulphatase in dexamethasone-induced and natural parturition.
J. Endocrinol.
122:
351-359,
1989[Abstract/Free Full Text].
15.
Mathew, J.,
and
A. S. Balasubramanian.
Arylsulphatase C and estrone sulphatase of sheep hypothalamus, preoptic area, and midbrain: separation by hydrophobic interaction chromatography and evidence for differences in their lipid environment.
J. Neurochem.
39:
1205-1209,
1982[Medline].
16.
Nathanielsz, P. W.,
C. Elsner,
D. Magyar,
D. Fridshal,
A. Freeman,
and
J. E. Buster.
Time trend analysis of plasma unconjugated and sulfoconjugated estrone and 3
-
5-steroids in fetal and maternal sheep plasma in relation to spontaneous parturition at term.
Endocrinology
110:
1402-1407,
1982[Abstract].
17.
Platia, M. P.,
M. Fencl,
K. E. Elkind-Hirsch,
J. A. Canick,
and
D. Tulchinsky.
Estrone sulfatase activity in the human brain and estrone sulfate levels in the normal menstrual cycle.
J. Steroid Biochem.
21:
237-241,
1984[Medline].
18.
Rosenfeld, C. R.,
R. J. Worley,
L. Milewich,
N. F. Grant,
and
R. Parker, Jr.
Ovine fetoplacental sulfoconjugation and aromatization of dehydroepiandrosterone.
Endocrinology
106:
1971-1979,
1980[Medline].
19.
Saoud, C. J.,
and
C. E. Wood.
Ontogeny and molecular weight of immunoreactive arginine vasopressin and corticotropin-releasing factor in the ovine fetal hypothalamus.
Peptides
17:
55-61,
1996[Medline].
20.
Saoud, C. J.,
and
C. E. Wood.
Modulation of ovine fetal adrenocorticotropin secretion by androstenedione and 17
-estradiol.
Am. J. Physiol.
272 (Regulatory Integrative Comp. Physiol. 41):
R1128-R1134,
1997[Abstract/Free Full Text].
21.
Simerly, R. B.,
C. Chang,
M. Muramatsu,
and
L. W. Swanson.
Distribution of androgen and estrogen receptor mRNA-containing cells in the rat brain: an in situ hybridization study.
J. Comp. Neurol.
294:
76-95,
1990[Medline].
22.
Stein, C.,
A. Hille,
J. Seidel,
S. Rijnbout,
A. Waheed,
B. Schmidt,
H. Geuze,
and
K. von Figura.
Cloning and expression of human steroid-sulfatase. Membrane topology, glycosylation, and subcellular distribution in BHK-21.
J. Biol. Chem.
264:
13865-13872,
1989[Abstract/Free Full Text].
23.
Strott, C. A.,
H. Sundel,
and
M. T. Stahlman.
Maternal and fetal plasma progesterone, cortisol, testosterone, and 17
-estradiol in preparturient sheep: response to fetal ACTH infusion.
Endocrinology
95:
1327-1339,
1974[Medline].
24.
Tsang, C. P. W.
Changes in plasma levels of estrone sulfate and estrone in the pregnant ewe around parturition.
Steroids
23:
855-868,
1974[Medline].
25.
Ward, D. G.,
M. G. Bolton,
and
D. S. Gann.
Inhibitory and facilitatory areas of the ventral midbrain mediating release of corticotropin in the cat.
Endocrinology
102:
1147-1154,
1978[Abstract].
26.
Winer, B. J.
Statistical Principles in Experimental Design. New York: McGraw-Hill, 1971, p. 514-603.
27.
Zar, J. H.
Biostatistical Analysis. Englewood Cliffs, NJ: Prentice-Hall, 1984.
Am J Physiol Regul Integr Compar Physiol 276(6):R1647-R1652
0002-9513/99 $5.00
Copyright © 1999 the American Physiological Society